Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Analyst Ratings for Starbucks

Starbucks (NASDAQ:SBUX) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview: Gulf Island Fabrication

Gulf Island Fabrication (NASDAQ:GIFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Gulf Island Fabrication will report an earnings per share (EPS) of $-0.17.

Benzinga

Why 'Amazon of Argentina' MercadoLibre Stock Looks Set To Bounce

MercadoLibre, Inc (NASDAQ: MELI) was plummeting an additional 13% lower on Monday to reach a 52-week low, after having plunged over 10% between May 5 and the start of the trading day.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyst Ratings for Intercept Pharmaceuticals

Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Outlook For Porch Group

Porch Group (NASDAQ:PRCH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Porch Group will report an earnings per share (EPS) of $-0.20.

Benzinga

Amid Domestic Violence Allegation, Longtime Seagen CEO Takes Leave of Absence

The Board of Directors of Seagen Inc (NASDAQ:SGEN) announced that its long-time president, CEO, and chairman Clay Siegall, is on a leave of absence. The move follows an alleged incident of domestic violence. While Siegall, who informed the company that he's in the middle of a divorce, denied those allegations. The Seagen board…

Benzinga

Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies

Twist Bioscience Corporation (NASDAQ:TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC:ALPMF) to conduct research activities to identify and optimize proprietary Twist antagonist antibodies. The antibodies will target an undisclosed checkpoint inhibitor pathway in the tumor microenvironment as potential therapeutic development candidates. Ligands in this pathway are…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

12 Industrials Stocks Moving In Monday's Intraday Session

Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga

11 Information Technology Stocks Moving In Monday's Intraday Session

Benzinga

10 Financials Stocks Moving In Monday's Intraday Session

Benzinga

Jim Cramer Unimpressed By Palantir Earnings: Why He Says The Software Stock Is 'Doing So Poorly'

The overall markets continue to decline as earnings season unfolds. Monday on CNBC's "Squawk On The Street," Jim Cramer pointed out a concerning commonality among smaller companies that have reported recently.

Benzinga

Viatris Posts Q1 Profit Despite 5% Dip In Sales, Reiterates FY22 Guidance Above Consensus

Viatris Inc (NASDAQ:VTRS) reported Q1 FY22 sales of $4.18 billion, down 5% Y/Y (-1% on an operational basis), below the consensus of $4.23 billion. Brands performed better than expectations, such as Lipitor, Effexor, and Perforomist. Complex generics and biosimilars grew by 21% Y/Y on an operational basis, driven mainly by the generic…

Benzinga

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

Benzinga

Affirm Holdings Whale Trades For May 09

A whale with a lot of money to spend has taken a noticeably bearish stance on Affirm Holdings. Looking at options history for Affirm Holdings (NASDAQ:AFRM) we detected 44 strange trades.

Benzinga

Preview: Paya Holdings's Earnings

Paya Holdings (NASDAQ:PAYA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Paya Holdings will report an earnings per share (EPS) of $0.08.

Benzinga

4 Analysts Have This to Say About Liberty Formula One Group

Liberty Formula One Group (NASDAQ:FWONK) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Lumos Pharma's Earnings: A Preview

Lumos Pharma (NASDAQ:LUMO) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Lumos Pharma will report an earnings per share (EPS) of $-0.89.

Benzinga

Earnings Outlook For Eos Energy Enterprises

Eos Energy Enterprises (NASDAQ:EOSE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Eos Energy Enterprises will report an earnings per share (EPS) of $-0.56.

Benzinga

Where Beacon Roofing Supply Stands With Analysts

Beacon Roofing Supply (NASDAQ:BECN) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Outlook For Exela Technologies

Exela Technologies (NASDAQ:XELA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Exela Technologies will report an earnings per share (EPS) of $-0.10.

Benzinga

Reata Pharmaceuticals Earnings Preview

Reata Pharmaceuticals (NASDAQ:RETA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Reata Pharmaceuticals will report an earnings per share (EPS) of $-2.15.

Benzinga

Earnings Preview For Atea Pharmaceuticals

Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Atea Pharmaceuticals will report an earnings per share (EPS) of $-0.58.

Benzinga

Krispy Kreme Debuts 'Oh, Honey! Collection' Of Doughnuts

Krispy Kreme Inc (NASDAQ: DNUT) is rolling out its latest product line with the limited edition "Oh, Honey! Collection." What Happened: According to the Charlotte, North Carolina-based company, the new collection will consist of three products:

1 … 451 452 453 454

People

Jim Cramer

261 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Eos Energy Enterprises

21 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.